Sio Capital Management, LLC Sio Gene Therapies Inc. Transaction History

Sio Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.07 - $2.89 $952,713 - $1.33 Million	-460,248 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$2.34 - $3.44 $997,815 - $1.47 Million	-426,417 Reduced 48.09%	460,248 $1.2 Million
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $1.69 Million - $4.99 Million	886,665 New	886,665 $2.47 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.